Separate paths lead to promising cholesterol drug
NEW YORK, Aug 26 (Reuters) - Discovery of one of the most promising cholesterol fighters in decades began in 1999 with Catherine Boileau, a Paris scientist who was seeking a genetic reason why 19 members of two French families she was studying had sky-high levels of "bad" LDL cholesterol.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here